Rowatinex, 10 ml, Rowa Wagner

Rowatinex drops are used for the prophylaxis and treatment of urinary lithiasis.

An adjunct in the treatment of urinary tract infections and mild to moderate kidney disease.

Ingredients:

100 g of oral drops, a solution containing alpha-pinem 24.8 g, beta-pinem 6.2 g, camphene 15 g, cineole 3 g, fenchone 4 g, borneol 10 g, and anethole 4 g, and the excipient: olive oil.

How to use:

• Adults: The usual dose is 3-5 oral drops of Rowatinex solution 4-5 times daily, 30 minutes before meals, or as directed by your doctor. On the advice of a doctor, during very painful periods, especially if colic pain occurs, a dose of 20-30 oral drops of Rowatinex solution is administered, which can be repeated after 15-20 minutes if necessary, or up to 40 oral drops are administered in a single dose
• Children aged 6 to 14 years: The usual dose is 1-2 oral drops of Rowatinex solution 3-4 times daily, 30 minutes before meals, or as directed by a doctor.

Adverse reactions:

• Mild and transient gastric disturbances have occasionally been reported
• Vomiting has been reported rarely
• Two mild cases of drug intolerance have been reported
• Allergic reactions, including delayed reactions, may occur.

Overdose:

• In case of overdose, gastric irritation with nausea, vomiting, and diarrhea may occur
• If the drug has been ingested recently, gastric lavage should be performed
• The patient should be carefully monitored and, if necessary, symptomatic treatment should be instituted
• Cardiac, respiratory, renal, and hepatic function should be monitored
• Toxicological studies in animals have shown that high doses of essential oils can cause central nervous system depression, including excitation and convulsions.

Precautions:

• Do not use after the expiration date printed on the package
• Do not store above 25 degrees Celsius in the original packaging
• Keep out of reach of children.

Special warnings:

Medical supervision is recommended for patients with renal colic.

Pregnancy and breastfeeding:

• Although no teratogenic effects have been reported, Rowatinex should not be administered during the first trimester of pregnancy
• Due to insufficient information, Rowatinex should not be administered to breastfeeding women
• Rowatinex does not affect the ability to drive or use machines.

Contraindications:

Severe renal colic, anuria, severe urinary tract infections, urinary calculi requiring surgical treatment.

Interactions:

Caution should be exercised in patients treated with anticoagulants or other drugs metabolized by the liver that have a narrow therapeutic index.

Presentation: 10 ml